These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2895844)

  • 21. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
    Schönitzer D; Frisch H
    Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is the best predictor of the severity of ABO-haemolytic disease of the newborn?
    Brouwers HA; Overbeeke MA; van Ertbruggen I; Schaasberg W; Alsbach GP; van der Heiden C; van Leeuwen EF; Stoop JW; Engelfriet CP
    Lancet; 1988 Sep; 2(8612):641-4. PubMed ID: 2901516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement is not activated in AB0-hemolytic disease of the newborn: further support.
    Carreras Vescio LA; Castro RA
    Vox Sang; 1990; 58(3):231. PubMed ID: 2339535
    [No Abstract]   [Full Text] [Related]  

  • 24. Destruction of IgG anti-A sensitized erythrocytes by mononuclear leucocytes from normal and ABO haemolytic disease affected infants.
    Romano EL; Rossi Devivo ML; Soyano A; Linares J
    Clin Exp Immunol; 1984 Feb; 55(2):451-8. PubMed ID: 6538121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characteristics of humoral immunity in hemolytic disease of newborn].
    Osipov AI; Kevorkov NN; Naĭgovzina NB
    Pediatriia; 1978 May; (5):20-3. PubMed ID: 566896
    [No Abstract]   [Full Text] [Related]  

  • 26. Complement is not activated in AB0-haemolytic disease of the newborn: two exceptions.
    Pujol M; Ribera A; Abella E; Natal A; Bel J; Coroleu W
    Vox Sang; 1991; 61(1):76. PubMed ID: 1949716
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of a positive Rhesus D neonate born of a mother with idiopathic thrombopenic purpura with anti-D immunoglobulins (Rh O)].
    di Maria H; Parnet Mathieu F; Rio di Maria D; Maigret P; Gire R; Guillot F; Lasfargues G; Brossard Y
    Arch Fr Pediatr; 1990 Feb; 47(2):125-7. PubMed ID: 2158285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Attempt at Rhesus-prevention at the end of pregnancy].
    Baumgarten K; Reinold E; Koller A
    Wien Med Wochenschr; 1972 Sep; 122(39):551-2. PubMed ID: 4631515
    [No Abstract]   [Full Text] [Related]  

  • 29. [Errors and disagreements in the determination of factor RhO (D)].
    Ducos J; Ruffié J; Marty Y
    Rev Fr Transfus; 1969; 12(1):Suppl:81-91. PubMed ID: 4987787
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibodies of Rh isoimmunization.
    Dibbern HH; Monroe CH; Jennings ER
    Obstet Gynecol; 1968 Dec; 32(6):805-12. PubMed ID: 4193259
    [No Abstract]   [Full Text] [Related]  

  • 31. [Preventive and therapeutic use of intravenous administration of immunoglobulins in intensive care patients in pediatrics].
    Leititis JU
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():29-34. PubMed ID: 8499748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of the 2-mercaptoethanol test to the diagnosis and prediction of hemolytic disease of the newborn due to ABO incompatibility].
    Buñuel C; Lucia JF; Raichs A
    Sangre (Barc); 1973; 18(1):15-20. PubMed ID: 4708548
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 34. ABO incompatibility due to immunoglobulin G anti-B antibodies presenting with severe fetal anaemia.
    Ziprin JH; Payne E; Hamidi L; Roberts I; Regan F
    Transfus Med; 2005 Feb; 15(1):57-60. PubMed ID: 15713130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development and present status of immunoprophylaxis of Rh-sensitization].
    Radzuweit H
    Z Arztl Fortbild (Jena); 1970 Dec; 64(3):1181-5. PubMed ID: 4994101
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention of Rh sensitization by means of anti D application].
    Schneider J
    Bibl Haematol; 1969; 32():113-23. PubMed ID: 4980798
    [No Abstract]   [Full Text] [Related]  

  • 37. [ABO immunological afectation of newborns, between heterospecific ABO pregnancy and haemolytic ABO disease. A study of 156 cases (author's transl)].
    Calabuig MT; Sanchez-Fayos J; Outeiriño J; Serrano J; Pérez Iglesias F; Pérez Piño T; Paniagua G
    Sangre (Barc); 1977; 22(4):409-20. PubMed ID: 897951
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma exchange and high-dose i.v. immunoglobulin in the treatment of severe rhesus hemolytic disease.
    Berlin G; Selbing A; Gottvall T
    Prog Clin Biol Res; 1990; 337():337-40. PubMed ID: 2112753
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the influence of maternal isoagglutinis on the ABO-incompatibility in newborn infants].
    Schneeweiss B; Brandt N
    Padiatr Grenzgeb; 1968; 7(4):225-33. PubMed ID: 5732839
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical aspects of Rh immunization. Philip Levine Award Address.
    Mollison PL
    Am J Clin Pathol; 1973 Sep; 60(3):287-301. PubMed ID: 4199486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.